October 31, 2013

Mylan experienced a slight dip in sales in its third quarter, due primarily to fluctuating currency values, the generic drug maker said Thursday.

October 17, 2013

Generic drug maker Mylan has appointed Jacek Glinka as president of its European division, the company said Thursday.

October 3, 2013

GNC Holdings on Wednesday announced it has acquired A1 Sports Limited (d.b.a. Discount Supplements), a multi-brand sports nutrition e-commerce retailer in the United Kingdom.

September 30, 2013

Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

September 27, 2013

Celebrity Chef Robert Irvine, along with nutritional products brand FortiFX, is pleased to announce the debut of a new line of six-layer baked meal-replacement bars — Fit Crunch Baked Bars — which are high in protein and low in sugar without compromising taste and texture.

September 25, 2013

Mylan is challenging the patent protection on a drug used to treat fibromyalgia, prompting a lawsuit from the branded drug's manufacturers.

September 3, 2013

Indian regulators have approved a deal from Mylan to buy the injectables business of Strides Arcolab, Mylan said Tuesday.

August 28, 2013

A consumer group is urging the Pennsylvania state legislature to increase access to vaccines for children and teenagers.

August 22, 2013

The Food and Drug Administration has approved a supplemental regulatory application from Mylan for a generic antidepressant that was subject last year to scrutiny by the agency amid reports of efficacy problems, Mylan said Thursday.

August 21, 2013

Clif Bar announced the two winners of the "Feed Your Strength ... At Work!" contest — Yurbuds, a St. Louis-based company that makes custom fit, high-end earphones; and 4Moms a company dedicated to making innovative baby products located in Pittsburgh.

August 6, 2013

GNC Holdings concluded its Total Lean Challenge and Sweepstakes, rewarding 13 participants with a share of $25,000 in cash and prizes.

August 6, 2013

Mylan's sales ticked up slightly in second quarter 2013, compared with the same period last year, the company said.

July 30, 2013

GNC on Monday named Carmine Fortino EVP business development. Fortino comes to GNC from Atrium Innovations, a Canadian natural health products company, where he was president. Fortino also was a former director of GNC from 2007 to 2011.

July 25, 2013

Mylan and Orion Corp. have settled a patent-infringement suit over a drug used to treat Parkinson's disease.

July 24, 2013

Mylan has settled with the makers of a drug used to treat cancer in a patent-infringement lawsuit, the generic drug maker said.

July 23, 2013

A federal court has ruled that a Mylan lawsuit against GlaxoSmithKline over an antidepressant drug can go to trial.

July 22, 2013

The Eastern retail landscape will continue to host the latest in Western ideas of wellness as GNC announced its expansion into the Chinese marketplace with the first stand-alone GNC store in Shanghai.

July 17, 2013

A federal court in New York has dismissed a lawsuit alleging that Mylan infringed four of Teva Pharmaceutical Industries' patents when it sought Food and Drug Administration approval for a multiple sclerosis drug.

July 16, 2013

Mylan has launched a generic contraceptive therapy, the drug maker said Tuesday.

July 15, 2013

Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.

July 11, 2013

Mylan is challenging a patent on a drug used to treat ulcerative proctitis, the generic drug maker said Thursday.

July 10, 2013

Many patients are not complying with their prescription drug therapies due to adverse side effects, even though some OTC drugs can treat them, according to a new study commissioned by a maker of products for dry mouth, one of the most common medication side effects.

July 8, 2013

A chronic obstructive pulmonary disease and asthma drug made by Sunovion infringes Mylan's patents on a similar drug, a federal judge has ruled, Mylan said.

July 2, 2013

GNC Holdings on Monday named Alan Feldman and Robert Moran to its board of directors.